Varian is changing the way we look at and treat cancer. Dr. Deepak 'Dee' Khuntia joins us for an incredible conversation about Varian's strategy in the fight against cancer.

A look at what's in store for medtech deals this year. Will 2022 be known as the year of Medtech M&A? Looks like it. EY's John Babitt joins us for a riveting conversation about EY's Annual M&A Firepower Report.

Omicron has caused quite a disruption in both pharma and medtech. Derron Stark EY-Parthenon Partner, Principal, Strategy Transactions, speaks about these supply chain issues.

Dr. Lishan Aklog wears multiple hats. He's the CEO of both PavMed and Lucid Diagnostics. Being a CEO of two companies during the pandemic can be tough at times, but Dr. Aklog's biggest challenge is getting out the awareness of how some instances of GERD can lead to Esophageal Cancer. Dr. Aklog stops by for an amazing conversation on how Lucid Diagnostics is making an impact in the detection of Esophageal Cancer.

Paul Grand, MTI's CEO and Glenn Synder, Deloitte's Principle medtech practice leader discuss startups.

Allisa Song discusses her role as CEO of Nanodropper, while still attending medical school.

Is medtech’s pulse strong? EY’s Jim Welch discusses the ‘industry's pulse in this all-new episode.

Dr. Antonia Chen shares her insight on why antibacterial sutures should be standard in operating rooms to prevent SSI's.

A look at what means to be a person of color in the medtech industry.

Marissa Fayer is a decorated veteran of medtech. Hear how she broke into the industry and how she founded HERHealthEQ to fight for women's health.